Navigation Links
Advanced Health Media, Inc. Announces New SVP Product Delivery

NEW PROVIDENCE, N.J., Sept. 9, 2011 /PRNewswire/ -- Advanced Health Media (AHM), the leading supplier of speaker program and commercial compliance management solutions for the pharmaceutical industry, has named Paul O'Toole as its new Senior Vice President of Product Delivery, effective immediately. Paul brings over 20 years of experience building and managing healthcare technology service organizations, including software and product development, implementation, professional services, and customer support.

"Paul will lead AHM's Product Delivery organization in Chesapeake, VA, and serve as a member of the AHM executive team," said James Burgess, AHM Chief Executive Officer. "He has an excellent background for leading AHM's technology enabled product and service offerings business. I have worked with Paul in the past and have complete confidence in his ability to help our organization reach the next level of product and service delivery."

Most recently, Paul was Senior Vice President of Operations at Healthland, a leading developer of rural hospital management software. Paul has also served as Vice President and Divisional General Manager of Mediware Information Systems Inc. and before that Global Services & Support Director of the Health Information Systems division of 3M. Prior to 3M, Paul held various management and executive positions at both VHA and IBM Corporation.

"I'm excited to join the AHM team. This organization is investing in more customer centric products and services using the most current technology platforms and I will be part of driving continued advancements in the business," adds Paul.

Paul received his Bachelor of Science Engineering degree at Northeastern University. He is also a certified Six Sigma Black Belt.

About AHM

Advanced Health Media, located in New Providence, NJ, provides technology enabled services specifically designed to drive compliance for the highly regulated pharmaceutical and life sciences industries. AHM's proprietary systems are used by many of the top pharmaceutical companies in the U.S. and by tens of thousands of pharmaceutical sales representatives and managers. AHM is a Microsoft Certified Partner company. For more information, please visit

SOURCE Advanced Health Media
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):